160 related articles for article (PubMed ID: 27285983)
1. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
[TBL] [Abstract][Full Text] [Related]
3. Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.
Shao H; Zhang J; Sun Z; Chen F; Dai X; Li Y; Ni Y; Xu K
Oncotarget; 2015 Jun; 6(16):14247-59. PubMed ID: 26036625
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Liu W; Zhang D; Feng Y; Li Y; Huang D; Jiang C; Gao M; Peng F; Wang X; Jing S; Jiang X; Ni Y; Zhang J
J Drug Target; 2015 May; 23(4):371-9. PubMed ID: 25572455
[TBL] [Abstract][Full Text] [Related]
5. Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.
Li J; Cona MM; Chen F; Feng Y; Zhou L; Zhang G; Nuyts J; de Witte P; Zhang J; Yu J; Oyen R; Verbruggen A; Ni Y
Theranostics; 2013; 3(2):127-37. PubMed ID: 23423247
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
[TBL] [Abstract][Full Text] [Related]
7. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
[TBL] [Abstract][Full Text] [Related]
8. Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis.
Ji Y; Zhan Y; Jiang C; Jiang X; Gao M; Liu W; Li Y; Wang J; Wang Q; Cona MM; Yao N; Wang X; Fang Z; Yin Z; Zhang J; Sun Z; Ni Y
J Drug Target; 2014 May; 22(4):304-12. PubMed ID: 24328682
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
[TBL] [Abstract][Full Text] [Related]
10. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.
Kong M; Zhang J; Jiang C; Jiang X; Li Y; Gao M; Yao N; Huang D; Wang X; Fang Z; Liu W; Sun Z; Ni Y
J Drug Target; 2013 Jul; 21(6):604-10. PubMed ID: 23627568
[TBL] [Abstract][Full Text] [Related]
11. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
[TBL] [Abstract][Full Text] [Related]
12. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
[TBL] [Abstract][Full Text] [Related]
13. Improved clearance of radioiodinated hypericin as a targeted anticancer agent by using a duodenal drainage catheter in rats.
Cona MM; Feng Y; Verbruggen A; Oyen R; Ni Y
Exp Biol Med (Maywood); 2013 Dec; 238(12):1437-49. PubMed ID: 24146264
[TBL] [Abstract][Full Text] [Related]
14. Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis.
Qi X; Shao H; Zhang J; Sun Z; Ni Y; Xu K
Radiol Med; 2015 Feb; 120(2):213-21. PubMed ID: 25012473
[TBL] [Abstract][Full Text] [Related]
15. Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models.
Li J; Cona MM; Chen F; Feng Y; Zhou L; Yu J; Nuyts J; de Witte P; Zhang J; Himmelreich U; Verbruggen A; Ni Y
Theranostics; 2012; 2(10):1010-9. PubMed ID: 23139728
[TBL] [Abstract][Full Text] [Related]
16. Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic 131I-hypericin in rat models.
Li Y; Jiang C; Jiang X; Sun Z; Cona MM; Liu W; Zhang J; Ni Y
Exp Biol Med (Maywood); 2015 Dec; 240(12):1764-73. PubMed ID: 25956680
[TBL] [Abstract][Full Text] [Related]
17. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
Liu X; Feng Y; Jiang C; Lou B; Li Y; Liu W; Yao N; Gao M; Ji Y; Wang Q; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Drug Target; 2015 Jun; 23(5):417-26. PubMed ID: 25655506
[TBL] [Abstract][Full Text] [Related]
18. Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy.
Li Y; Wang S; Jiang X; Wang X; Zhou X; Wan L; Zhao H; Zhou Z; Gao L; Huang G; Ni Y; He X
Int J Pharm; 2021 Apr; 599():120393. PubMed ID: 33639227
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the therapeutic efficacy of sequential therapy involving percutaneous microwave ablation in combination with 131I-hypericin using the VX2 rabbit breast solid tumor model.
Zhu M; Lin XA; Zha XM; Zhou WB; Xia TS; Wang S
PLoS One; 2015; 10(3):e0120303. PubMed ID: 25799220
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
Jin Q; Zhao J; Gao M; Feng Y; Liu W; Yin Z; Li T; Song S; Ni Y; Zhang J; Huang D; Zhang D
Mol Imaging Biol; 2018 Aug; 20(4):551-561. PubMed ID: 29305726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
